Phillip A. Sharp Innovation in Collaboration Award: Precision Combinatorial Immunotherapeutic Targeting of Thymic Stromal Lymphopoietin Receptor (TSLPR) Signaling in Pediatric and Young Adult CRLF2-Rearranged ALL - Stand Up To Cancer

Blog

Posted October 9, 2019

Phillip A. Sharp Innovation in Collaboration Award: Precision Combinatorial Immunotherapeutic Targeting of Thymic Stromal Lymphopoietin Receptor (TSLPR) Signaling in Pediatric and Young Adult CRLF2-Rearranged ALL

JOIN OUR COMMUNITY

Sign up to receive emails from Stand Up To Cancer.
   Please leave this field empty
Stand Up to Cancer

Thanks for signing up!
You will hear from us soon.